Medicare Enrolled

Dr. Linda Pao, MD

Neurology · Jupiter, FL
Low-engagement
601 UNIVERSITY BLVD, Jupiter, FL 33458
5616273381
In practice since 2006 (19 years)
NPI: 1417973827 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Pao from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Pao? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Pao

Dr. Linda Pao is a neurology in Jupiter, FL, with 19 years in practice.

Between the years covered by Open Payments, Dr. Pao received a total of $22,442 from 78 pharmaceutical and/or device companies across 830 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Pao is High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice$ $22,442 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$22,442
Total received (2018-2024)
Avg $3,206/year across 7 years
Top 14% in FL for neurology
78
Companies
830
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$18,619 (83.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$3,505 (15.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$318 (1.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,201
2023
$3,810
2022
$2,952
2021
$3,592
2020
$2,233
2019
$4,281
2018
$3,373

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Eisai Inc.
$3,752
Novartis Pharmaceuticals Corporation
$1,308
GENZYME CORPORATION
$1,205
Biogen, Inc.
$1,059
E.R. Squibb & Sons, L.L.C.
$1,019
EMD Serono, Inc.
$851
Merck Sharp & Dohme LLC
$799
Lilly USA, LLC
$760
Adamas Pharmaceuticals, Inc.
$659
ACADIA Pharmaceuticals Inc
$591
Amgen Inc.
$578
US WorldMeds, LLC
$479
Lundbeck LLC
$461
Teva Pharmaceuticals USA, Inc.
$455
Allergan, Inc.
$453
Amneal Pharmaceuticals LLC
$442
AbbVie Inc.
$437
UCB, Inc.
$426
Alexion Pharmaceuticals, Inc.
$389
Genentech USA, Inc.
$370
Abbott Laboratories
$365
Acorda Therapeutics, Inc
$337
Stryker Corporation
$308
Biohaven Pharmaceuticals, Inc.
$299
Supernus Pharmaceuticals, Inc.
$296
Allergan Inc.
$251
ABBVIE INC.
$214
Neurocrine Biosciences, Inc.
$212
La Jolla Pharmaceutical Company
$211
Avanir Pharmaceuticals, Inc.
$208
Neurelis, Inc.
$192
Janssen Pharmaceuticals, Inc
$187
Celgene Corporation
$180
ARBOR PHARMACEUTICALS, INC.
$161
Sunovion Pharmaceuticals Inc.
$156
Grifols USA, LLC
$138
ABIOMED
$130
Silk Road Medical, Inc.
$127
GRT US Holding, Inc.
$124
Chiesi USA, Inc.
$122
Heron Therapeutics, Inc.
$122
SK Life Science, Inc.
$105
Kyowa Kirin, Inc.
$95
ARGENX US, INC.
$94
Biohaven Pharmaceutical Holding Company Ltd.
$93
Harmony Biosciences LLC
$92
LivaNova USA, Inc.
$91
Upsher-Smith Laboratories LLC
$82
Impax Laboratories, Inc.
$73
PFIZER INC.
$73
ITF Pharma, Inc.
$73
Bausch Health US, LLC
$54
Almatica Pharma LLC
$48
CSL Behring
$48
Merz Pharmaceuticals, LLC
$46
Novo Nordisk Inc
$46
HARMONY BIOSCIENCES LLC
$45
AbbVie, Inc.
$42
Egalet US Inc
$41
Mallinckrodt LLC
$35
Ipsen Biopharmaceuticals, Inc
$31
UCB SA
$26
Merck Sharp & Dohme Corporation
$24
MITSUBISHI TANABE PHARMA AMERICA, INC.
$23
UPSHER-SMITH LABORATORIES LLC
$22
Shire North American Group Inc
$21
EISAI INC.
$20
Corium, LLC
$19
ASSERTIO THERAPEUTICS, Inc.
$18
Arbor Pharmaceuticals, Inc.
$18
Pernix Therapeutics Holdings, Inc.
$17
MERZ NORTH AMERICA, INC.
$16
Vertical Pharmaceuticals, LLC
$16
Scilex Pharmaceuticals Inc.
$15
SCILEX PHARMACEUTICALS INC.
$14
Piramal Imaging Limited
$14
Avion Pharmaceuticals
$13
KVK-Tech, Inc.
$3
Top 3 companies account for 27.9% of total payments
Associated products mentioned in payments ›
ACTHAR · ADLARITY · ADUHELM · AIMOVIG · AJOVY · ALLOWRAP · AMPYRA · AMYVID · APOKYN · APONVIE · AUBAGIO · AUSTEDO · AVONEX · Aimovig · BELSOMRA · BOTOX · BOTOX THERAPEUTIC · Briviact · CLEVIPREX · COPAXONE · Cambia · DISEASE STATE · DUOPA · DYSPORT · Dhivy · Duopa · EMGALITY · ENROUTE Transcarotid Neuroprotection System · Fycompa · GAMMAGARD · GIAPREZA · GILENYA · GOCOVRI · GRALISE · Gamunex-C · Hizentra · Horizant · INBRIJA · INGREZZA · Impella · Infinity DBS Pulse Generators · KESIMPTA · KISUNLA · KYNMOBI · LEMTRADA · LYRICA · Leqembi · MAYZENT · MIGRANAL · MOUNJARO · MYOBLOC · Mavenclad · Mitra Clip system · NAMZARIC · NAPRELAN · NEURACEQ · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · Nuedexta · OCREVUS · ONGENTYS · OSMOLEX ER · Ocrevus · Ongentys · PLEGRIDY · Ponvory · QUDEXY XR TOPIRAMATE EXTENDED RELEASE CAPSULES · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · Qutenza · RADICAVA · REXULTI · RYTARY · Rebif · SOLIRIS · SPRIX · Soliris · TECFIDERA · TROKENDI XR · TYSABRI · Tiglutik · Tosymra Sumatriptan Nasal Spray · UBRELVY · ULTOMIRIS · VALTOCO · VARIAX · VNS Therapy · VNS Therapy SenTiva Model 1000 Generator · VUMERITY · VYEPTI · VYVGART · Vimpat · Wakix · XARELTO · XEOMIN · Xadago · Xeomin · ZEMBRACE SYMTOUCH · ZEMBRACE SYMTOUCH SUMATRIPTAN INJECTION · ZEPOSIA · ZOHYDRO ER · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (83%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a neurology in Jupiter?
Compare neurologys in the Jupiter area by procedure volume, costs, and industry payment transparency.
Browse neurologys nearby

Geographic Context

Neurologys within 10 mi
63
Per 100K population
4.2
County median income
$81,115
Nearest hospital
JUPITER MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data— No dataN/A
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Pao is a neurology, and high industry engagement (low-engagement, top 14%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Pao receive payments from pharmaceutical companies?
Yes. Dr. Pao received a total of $22,442 from 78 companies across 830 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Pao) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →